Blue light-filtering intraocular lens
Blue light-filtering intraocular lens has been studied in 3 papers since 2021: 2 observational studies in people, 1 review; 1 in the past year. The newest paper, Jan 16, 2026: “Mental disorders associated with cataract and its surgical treatment with intraocular lens implantation: a review”.
3 papers study it4 findingsUpdated
See all 3 papers on blue light-filtering intraocular lens
At a glance
The findings reach people, from one lab or study. 2 independent labs in 2 countries.
“Both Cox and Fine-Gray models showed significantly lower fall risks for premium BF-IOL (HR 0.86, SHR 0.92) and premium non-BF-IOL (HR 0.88, SHR 0.91) compared to standard IOLs.”
1 of its findings points the other way.
- 2 independent labs in 2 countries
- 1 finding against
- Funders: Chang Gung Medical Foundation, Taiwan and 2 more
- Humans2
What did studies of blue light-filtering intraocular lens find?
3Studies of blue light-filtering intraocular lens measured 3 outcomes; the most studied are sleep disturbances (1 study), falls (1) and wet age-related macular degeneration (1).
Sleep disturbances
no changein humans1
1 study
Sleep disturbances
no changein humans1
Blue light-filtering intraocular lens showed no clear effect on sleep disturbances in humans.
“the scientific data showed that the use of blue-light–filtering intraocular lenses does not increase the risk of sleep disturbances.”
Review
Neurology Bulletin
Falls
no changein humans1
1 study
Falls
no changein humans1
Blue light-filtering intraocular lens were not clearly linked with falls in humans (compared to premium non-BF-IOL) (HR/SHR 0.99).
“There was no significant difference in fall risk between premium BF-IOL and premium non-BF-IOL (HR/SHR 0.99).”
Humanscompared to premium non-BF-IOL
Biomedical journal
Wet age-related macular degeneration
no changein humans1
1 study
Wet age-related macular degeneration
no changein humans1
Blue light-filtering intraocular lens were not clearly linked with wet age-related macular degeneration in pseudophakic patients (62.8% vs 63.3%, p = 0.92).
“Among patients with wet AMD, 62.8% had a blue light-filtering IOL compared with 63.3% among control patients (p = 0.92).”
Humansin pseudophakic patients
Clinical ophthalmology (Auckland, N.Z.)
What is blue light-filtering intraocular lens linked with?
1Studies link blue light-filtering intraocular lens with 1 measure, most often falls (1 study).
Falls
downin humans1HR 0.86
1 study
Falls
downin humans1HR 0.86
Blue light-filtering intraocular lens are linked with a lower risk of falls in humans (compared to standard IOLs) (HR 0.86, SHR 0.92).
“Both Cox and Fine-Gray models showed significantly lower fall risks for premium BF-IOL (HR 0.86, SHR 0.92) and premium non-BF-IOL (HR 0.88, SHR 0.91) compared to standard IOLs.”
Humanscompared to standard IOLs
Biomedical journal